Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Healthcare | 17.49% |
| 3 | Consumer Discretionary | 17.05% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Repligen
RGEN
$8.1B
| $11.1M | 0.01% |
211,057
+2,367
| +1% | +$139K |
|
427
Range Resources
RRC
$9.24B
| $10.6M | 0.01% |
1,103,618
-162,001
| -13% | -$2.46M |
|
|
SYNH
428
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.5M | 0.01% |
267,738
+1,622
| +0.6% | +$75.4K |
|
429
Bank OZK
OZK
$5.57B
| $10.5M | 0.01% |
461,282
-1,190,816
| -72% | -$33M |
|
|
EQM
430
DELISTED
EQM Midstream Partners, LP
EQM
| $10.5M | 0.01% |
242,464
-11,360
| -4% | -$542K |
|
|
BAND
431
Bandwidth Inc
BAND
$1.25B
| $10.4M | 0.01% |
+255,359
| New | +$12M |
|
432
National Vision
EYE
$1.79B
| $10.3M | 0.01% |
+363,980
| New | +$13.9M |
|
|
BPMC
433
DELISTED
Blueprint Medicines
BPMC
| $10.1M | 0.01% |
187,849
-34,691
| -16% | -$2.11M |
|
434
Spyre Therapeutics
SYRE
$8.81B
| $10.1M | 0.01% |
54,072
-7,224
| -12% | -$1.53M |
|
435
Freeport-McMoran
FCX
$91.2B
| $9.97M | 0.01% |
967,152
-95,685
| -9% | -$1.12M |
|
|
PARA
436
DELISTED
Paramount Global Class B
PARA
| $9.91M | 0.01% |
226,649
-5,989
| -3% | -$318K |
|
437
XPO
XPO
$23.4B
| $9.86M | 0.01% |
499,893
-1,642,300
| -77% | -$45.5M |
|
438
ProPetro Holding
PUMP
$1.33B
| $9.72M | 0.01% |
788,642
-146,271
| -16% | -$2.41M |
|
|
FOCS
439
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $9.54M | 0.01% |
362,325
+1,457
| +0.4% | +$50.8K |
|
440
Sunrun
RUN
$2.27B
| $9.5M | 0.01% |
872,429
+18,388
| +2% | +$232K |
|
441
Western Midstream Partners
WES
$19.6B
| $9.5M | 0.01% |
342,485
-16,048
| -4% | -$482K |
|
|
AIMT
442
DELISTED
Aimmune Therapeutics
AIMT
| $9.29M | 0.01% |
388,458
-44,518
| -10% | -$1.15M |
|
443
BrightView Holdings
BV
$1.23B
| $9.06M | 0.01% |
887,281
-24,898
| -3% | -$320K |
|
444
Agios Pharmaceuticals
AGIO
$1.95B
| $8.92M | 0.01% |
193,531
-1,839
| -0.9% | -$114K |
|
|
THR
445
DELISTED
Thermon Group Holdings
THR
| $8.87M | 0.01% |
+437,132
| New | +$9.85M |
|
446
Patterson-UTI
PTEN
$3.74B
| $8.83M | 0.01% |
853,016
-445,836
| -34% | -$6.57M |
|
447
Steel Dynamics
STLD
$36.2B
| $8.81M | 0.01% |
293,161
-164,820
| -36% | -$6.23M |
|
|
GSKY
448
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $8.75M | 0.01% |
913,990
+162,280
| +22% | +$1.89M |
|
449
Douglas Emmett
DEI
$2.02B
| $8.73M | 0.01% |
+255,947
| New | +$9.19M |
|
450
Diageo
DEO
$49.5B
| $8.63M | 0.01% |
60,898
-88,967
| -59% | -$12.5M |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.